|

Engineering Tumor Infiltrating Lymphocytes Clinical Trials

1 actively recruiting trial

Also known as: GC203 TIL

Pipeline

Phase 1: 1

Top Sponsors

  • Shanghai Juncell Therapeutics1

Indications

  • Gastrointestinal Cancer1
  • Gynecologic Cancer1
  • Solid Tumor1
  • Lung Cancer1
  • Breast Cancer1

Other1 trial

A Study of GC203 TIL in Advanced Malignant Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.